Skip to main content
Log in

Überwachung von DNA-Schäden an Kontrollpunkten des Zellzyklus

  • Anwendungen & Produkte
  • Durchflusszytometrie
  • Published:
BIOspektrum Aims and scope

Zusammenfassung

In der vorgestellten Studie werden Arzneimittel-induzierte DNA-Schäden und deren Wirkung im Zellzyklus mittels Durchflusszytometrie bestimmt. Somit kann Durchflusszytometrie eine Hochdurchsatz-Plattform für das Screening niedermolekularer Krebsmedikamente darstellen.

Abstract

In this study, flow cytometry is used to measure drug-induced DNA damage and positioning of this damage within the cell cycle. The data suggest that flow cytometry is a high content platform for screening small molecule cancer drugs.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Literatur

  1. Kaufmann WK, Paules RS (1996) DNA damage and cell cycle checkpoints. FASEB J 10:238–247

    PubMed  CAS  Google Scholar 

  2. Zhao H, Traganos F, Darzynkiewicz Z (2010) Kinetics of the UV-induced DNA damage response in relation to cell cycle phase. Correlation with DNA replication. Cytometry A 77:285–293

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Matthew Hsu.

Additional information

Jason Whalley (links) und Matthew Hsu

Rights and permissions

Reprints and permissions

About this article

Cite this article

Santos, M., Zhang, W., White, L. et al. Überwachung von DNA-Schäden an Kontrollpunkten des Zellzyklus. Biospektrum 17, 200–202 (2011). https://doi.org/10.1007/s12268-011-0032-4

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12268-011-0032-4

Navigation